Arvinas website screenshot

Arvinas

Arvinas is a clinical-stage biopharmaceutical company (NASDAQ: ARVN) headquartered in New Haven, Connecticut, developing targeted protein degradation therapeutics using its proprietary PROTAC (proteolysis targeting chimera) Discovery Engine. PROTAC molecules are heterobifunctional protein degraders that harness the body's natural protein-disposal system to eliminate disease-causing proteins rather than merely inhibiting them, with a therapeutic focus on oncology and neurology. Arvinas developed the first FDA-approved PROTAC protein degrader, VEPPANU (vepdegestrant). The company was founded on research from Yale University and maintains research partnerships across the industry. This profile was surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network; Arvinas is a life-sciences company and does not publish a public developer API surface.

Arvinas is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceutical, Protein Degradation, and PROTAC.

🌐 Visit website 📡 Source on GitHub
13.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalProtein DegradationPROTACOncologyNeurologyLife SciencesDrug Discovery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 13.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arvinas: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Arvinas Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: arvinas
name: Arvinas
description: 'Arvinas is a clinical-stage biopharmaceutical company (NASDAQ: ARVN) headquartered in New Haven, Connecticut,
  developing targeted protein degradation therapeutics using its proprietary PROTAC (proteolysis targeting chimera) Discovery
  Engine. PROTAC molecules are heterobifunctional protein degraders that harness the body''s natural protein-disposal system
  to eliminate disease-causing proteins rather than merely inhibiting them, with a therapeutic focus on oncology and neurology.
  Arvinas developed the first FDA-approved PROTAC protein degrader, VEPPANU (vepdegestrant). The company was founded on research
  from Yale University and maintains research partnerships across the industry. This profile was surfaced as a portfolio company
  of Canaan Partners and added to the API Evangelist network; Arvinas is a life-sciences company and does not publish a public
  developer API surface.'
url: https://raw.githubusercontent.com/api-evangelist/arvinas/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceutical
- Protein Degradation
- PROTAC
- Oncology
- Neurology
- Life Sciences
- Drug Discovery
image: https://arvinas.b-cdn.net/wp-content/uploads/2024/10/OG_Logo.jpg
apis: []
common:
- type: Website
  url: https://www.arvinas.com/
- type: PrivacyPolicy
  url: https://www.arvinas.com/privacy-policy/
- type: TermsOfService
  url: https://www.arvinas.com/terms-of-use/
- type: DomainSecurity
  url: security/arvinas-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence